Cytokine mRNA abundance in intestinal biopsies from dogs with chronic diarrhea

Veterinarni Medicina

Volumn 52, Issue 8, 2007, Pages 353-364

  Sauter, S N ^a   Allenspach, K ^a   Blum, J W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Canine; Chronic enteropathy; Colon; Cytokines; Duodenum

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 34547456036     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/1876-VETMED     Document Type: Article

References (47)

1. Abbas A.K., Murphy K.M., Sher A. (1996): Functional diversity of helper T lymphocytes. Nature, 31, 787-793
2. Allenspach K., Gaschen F. (2003): Canine chronic enteropathies: a review. Schweizer Archiv für Tierheilkunde, 145, 209-222
3. Allenspach K., Luckschander N., Styner M., Seibold F., Doherr M., Aeschbach D., Gaschen F. (2004): Evaluation of assays for perinuclear anti neutrophilic cytoplasmatic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. American Journal of Veterinary Research, 65, 1279-1283
4. Cave N.J. (2003): Chronic inflammatory disorders of the gastrointestinal tract of companion animals. New Zealand Veterinary Journal, 51, 262-274
5. Craven M., Simpson J.W., Ridyard A.E., Chandler M.L. (2004): Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). Journal of the Small Animal Practitioner, 45, 336-342
6. Desreumaux P., Brandt E., Gambiez L., Emilie D., Geboes K., Klein O., Ectors N., Cortot A., Capron M., Colombel J.F. (1997): Distinct cytokine patterns in early and chronic ileal lesions of Crohn's Disease. Gastroenterology, 113, 118-126
7. Ferreira M. (2003): Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators of Inflammation, 12, 259-267
8. Fujiwara S., Yasunaga S., Nakayama H., Doi K., Masuda K., Ohno K., Tsujimoto H. (2002): Quantitative analysis of cytokine messenger RNAas in the duodenal mucosa in dogs with small intestinal inflammatory bowel disease. In: Proceedings of the American Clinical Veterinary Internal Medicine, 2002, Dallas, TX, USA
9. Garden O.A., Elwood C.M., Desport M., Batt R.M. (1999): In situ hybridization as a technique for the immunological investigation of canine intestine: jejunal expression of IFN-γ and IL-10 in Irish setters and beagles. Veterinary Immunology and Immunopathology, 70, 1-17
10. German A.J., Helps C.R., Hall E.J., Day M.J. (2000): Cytokine mRNA expression in mucosal biopsies from German Shepherd dogs with small intestinal enteropathies. Digestive Disease Science, 45, 7-17
11. German A.J., Hall E.J., Day M.J. (2001): Immune cell population within the duodenal mucosa of dogs with enteropathies. Journal of Veterinary Internal Medicine A, 15, 14-25
12. Goldstein R.E., Greiter-Wilke A., McDonough S.P., Simpson K.W. (2003): Quantitative evaluation of inflammatory and immune responses in cats with inflammatory bowel disease. In: Proceedings of the American Clinical Veterinary Internal Medicine, 2003, Charlotte, NC, USA
13. Greger D.L., Gropp F., Morel C., Sauter S., Blum J.W. (2006): Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies. Domestic Animal Endocrinology, 31, 76-87
14. Grimble RF. (2003): Inflammatory response in the elderly. Current Opinions on Clinical Nutrition and Metabolic Care, 6, 21-29
15. Holscher C. (2004): The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Medical Microbiology and Immunology, 193, 1-17
16. Huang H., Patel D.D., Manton K.G. (2005): The immune system in aging: roles of cytokines, T cells and NK cells. Frontiers in Bioscience, 10, 192-215
17. Jergens A.E., Sonea I.M., Kauffman L., Evans B., Wannemuehler M.J. (2003a): Cytokine mRNA expression in intestinal biopsies of dogs with inflammatory bowel disease. In: Proceedings of the American Clinical Veterinary Internal Medicine, 2003, Charlotte, NC, USA
18. Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., Eckersall P.D., Benson T.J., Evans R. (2003b): A scoring index for disease activity in canine inflammatory bowel disease. Journal of Veterinary Internal Medicine, 17, 291-297
19. Kato M., Kephart G.M., Telley N.J., Wagner J.M., Sarr M.G., Bonno M., McGovern T.W., Gleich G.J. (1998): Eosinophil infiltration and degranulation in normal human tissue. Anatomical Records, 252, 418-425
20. Kraft W., Dürr U.M. (1999): Referenzbereiche. In: Kraft W., Durr U.M. (eds.): Klinische Labordiagnostik in der Tiermedizin. Schattauer, Stuttgart, Germany. 344-359
21. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. (1993): Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 22, 262-274
22. Langmann T., Moehle C., Mauerer R., Scharl M., Liebisch G., Zahn A., Stremmel W., Schmitz G. (2004): Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology, 127, 26-40
23. Letterio J.J., Roberts A.B. (1998): Regulation of immune responses by TGF-β. Annual Review of Immunology, 16, 137-161
24. Li M.C., He S.H. (2004): IL-10 and its related cytokines for treatment of inflammatory bowel disease. World Journal of Gastroenterology, 10, 620-625
25. Lindsay J.O., Sandison A., Cohen P., Brennan F.M., Hodgson H.J.F. (2004): IL-10 gene therapy is therapeutic for dextran sodium sulphate-induced murine colitis. Digestive Disease Science, 49, 1327-1334
26. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., Vadas M.A. (1988): Recombinant human interleukin 5 is a selective activator of human eosinophil function. Journal of Experimental Medicine, 167, 219-224
27. Melgar S., Yeung M.M.W., Bas A., Forsberg G., Suhr O., Oberg A., Hamarstrom S., Danielsson A., Hammarstrom M.L. (2003): Over-expression of interleukin-10 in mucosal T cells of patients with active ulcerative colitis. Clinical Experimental Immunology, 134, 127-137
28. Monteleone G., Mann J., Monteleone I., Vavassori R., Bremner M., Fantini M., Del Vecchio G., Blanco R., Tersigni R., Alessandroni L., Mann D., Pallone F., MacDonald T.T. (2004): A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. Journal of Biological Chemistry, 279, 3925-3932
29. Moore K.W., de Wall Malefyt R., Coffman R.L., O'Garra A. (2001): Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology, 19, 683-765
30. Moxley G., Posthuma D., Carlson P., Estrada E., Han J., Benson L.L., Neale M.C. (2002): Sexual dimorphism in innate immunity. Arthritis and Rheumatology, 46, 250-258
31. Panwala C.M., Jones J.C., Viney J.L. (1998): A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, Mdr1a, spontaneously develop colitis. Journal of Immunology, 161, 5733-5744
32. Peters I.R., Helps C.R., Calvert R.L., Day M.J. (2005a): Cytokine mRNA quantification in histologically normal canine duodenal mucosa by real-time PCR. Veterinary Immunology and Immunopathology, 103, 101-111
33. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., Day M.J., (2005b): Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by realtime transcriptase polymerase chain reaction. Journal of Veterinary Internal Medicine A, 19, 644-653
34. Pizarro T.T., Arseneau K.O., Bamias G., Cominelli F. (2003): Mouse models for the study of Crohn's disease. Trends in Molecular Medicine, 9, 218-222
35. Ridyard A., Nuttall T.J., Else R.W., Simpson W., Miller H.R.P. (2002): Evaluation of Th1, Th2 and immunosuppressive cytokine mRNA expression within the colonic mucosa of dogs with idiopathic lymphocytic-plasmacytic colitis. Veterinary Immunology and Immunopathology, 86, 205-214
36. Rothenberg M.E. (2004): Eosinophilic gastrointestinal disorders. Journal of Allergy and Clinical Immunology, 113, 11-28
37. Rousseaux C., Lefebvre B., Dubuquoy L., Lefebvre P., Romano O., Auwerx J., Metzger D., Wahli W., Desvergne B., Naccari G.C., Chavatte P., Farce A., Bulois P., Cortot A., Colombel J.F., Desreumaux P. (2005): Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ. Journal of Experimental Medicine 201, 1205-1215
38. Sandborn W.J. (2005) New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Reviews on Gastroenterological Diseases, 5, 10-18
39. Sauter S.N., Allenspach K., Gaschen F., Grone A., Ontsouka E., Blum J.W. (2005): Cytokine expression in an ex-vivo culture system of duodenal samples from dogs with chronic enteropathies: modulation by probiotic bacteria. Domestic Animal Endocrinology, 29, 605-622
40. Sauter S.N., Benycoub J., Allenspach K., Gaschen F., Ontsouka E., Reuteler G., Knorr R., Blum J.W. (2006): Effects of probiotic bacteria in dogs with food responsive diarrhea. Journal of Animal Physiology and Animal Nutrition, 90, 269-277
41. Simpson S.J., Shah S., Comiskey M., de Jong Y.P., Wang B., Mizoguchi E., Bhan A.K., Terhorst C. (1998): T-cell mediated pathology in two model of experimental colitis depends predominantly on the interleukin-12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. Journal of Experimental Medicine, 187, 1225-1234
42. Spichiger A.C., Allenspach K., Ontsouka E., Gaschen F., Morel C., Blum J.W., Sauter S.N. (2005): Abundance of mRNA of growth hormone receptor and insulin-like growth factors-1 and-2 in duodenal and colonic samples of dogs with chronic enteropathies. Journal of Veterinary Medicine A, 52, 491-497
43. Spichiger A.C., Allenpach K., Zbinden Y., Doherr M.G., Hiss S., Blum J.W., Sauter S.N. (2006): Plasma insulin-like growth factor 1 concentration in dogs with chronic enteropathies. Veterinarni medicina, 51, 35-43
44. Vainer B., Nielsen O.H., Hendel J., Horn T., Kirman I. (2000): Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokines, 12, 1531-1536
45. Vassalli P. (1992): The pathology of tumor necrosis factors. Annual Reviews of Immunology, 10, 411-452
46. Willard M.D., Jergens A.E., Duncan R.B., Leib M.S., Mc-Cracken M.D., DeNovo R.C., Helman R.G., Slater M.R., Harbison J.L. (2002): Interobserver variation among histopathological evaluations of intestinal tissue from dogs and cats. Journal of the American Veterinary Medical Association, 220, 1177-1182
47. Wynn T.A. (2003): IL-13 effector functions. Annual Review of Immunology, 21, 425-456